Annual Drug Patent Expirations for MYFEMBREE
Myfembree is a drug marketed by Myovant Sciences and is included in one NDA. It is available from one supplier. There are six patents protecting this drug.
This drug has one hundred and fifteen patent family members in thirty-four countries.
The generic ingredient in MYFEMBREE is estradiol; norethindrone acetate; relugolix. One supplier is listed for this compound. Additional details are available on the estradiol; norethindrone acetate; relugolix profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
